USANA Health Sciences (NYSE:USNA) CFO G Doug Iiekking Sells 5,360 Shares

USANA Health Sciences, Inc. (NYSE:USNA) CFO G Doug Iiekking sold 5,360 shares of the stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $18.75, for a total transaction of $100,500.00. The transaction was disclosed in a filing with the SEC, which is available through this link.

USANA Health Sciences Stock Up 0.5%

USANA Health Sciences stock opened at $18.90 on Friday. USANA Health Sciences, Inc. has a twelve month low of $16.60 and a twelve month high of $38.32. The firm has a 50 day moving average price of $18.29 and a 200-day moving average price of $19.47. The company has a market capitalization of $348.93 million, a P/E ratio of 40.22, a P/E/G ratio of 0.74 and a beta of 0.77.

USANA Health Sciences (NYSE:USNA) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.44 by $0.17. The firm had revenue of $250.22 million during the quarter, compared to the consensus estimate of $240.99 million. USANA Health Sciences had a net margin of 0.96% and a return on equity of 6.21%. USANA Health Sciences has set its FY 2026 guidance at 1.950-2.290 EPS. Equities analysts expect that USANA Health Sciences, Inc. will post 2.12 EPS for the current fiscal year.

Hedge Funds Weigh In On USANA Health Sciences

A number of large investors have recently modified their holdings of USNA. National Bank of Canada FI lifted its stake in USANA Health Sciences by 166.6% in the 3rd quarter. National Bank of Canada FI now owns 1,922 shares of the company’s stock worth $53,000 after purchasing an additional 1,201 shares in the last quarter. Tower Research Capital LLC TRC lifted its stake in USANA Health Sciences by 382.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 2,398 shares of the company’s stock worth $73,000 after purchasing an additional 1,901 shares in the last quarter. State of Wyoming purchased a new stake in USANA Health Sciences in the 1st quarter worth approximately $57,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in USANA Health Sciences by 52.9% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,834 shares of the company’s stock worth $106,000 after purchasing an additional 1,327 shares in the last quarter. Finally, Parallel Advisors LLC lifted its stake in USANA Health Sciences by 1,354.3% in the 4th quarter. Parallel Advisors LLC now owns 3,854 shares of the company’s stock worth $76,000 after purchasing an additional 3,589 shares in the last quarter. 54.25% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on USNA shares. Wall Street Zen downgraded shares of USANA Health Sciences from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Weiss Ratings reiterated a “sell (d)” rating on shares of USANA Health Sciences in a research note on Friday, March 27th. Finally, Zacks Research downgraded shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Reduce”.

About USANA Health Sciences

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.